SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Tseng Labs Inc – ‘8-K’ for 6/23/98

As of:  Thursday, 6/25/98   ·   For:  6/23/98   ·   Accession #:  950116-98-1363   ·   File #:  0-13502

Previous ‘8-K’:  ‘8-K’ on 2/5/98 for 12/16/97   ·   Next & Latest:  ‘8-K’ on / for 11/3/98

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 6/25/98  Tseng Labs Inc                    8-K:5,7     6/23/98    3:224K                                   St Ives Financial/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                         3     10K 
 2: EX-2        Plan of Acquisition, Reorganization                   75    321K 
 3: EX-99.1     Miscellaneous Exhibit                                  2     11K 


8-K   —   Current Report
Document Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page   -   Filing Submission
2Item 5. Other Events
"Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
8-K1st Page of 3TOCTopPreviousNextBottomJust 1st
 

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 23, 1998 -------------- TSENG LABS, INC. (Exact Name of Registrant Specified in Charter) Utah 0-13502 87-0391229 --------------- ---------------- ------------------- (State or Other (Commission File (I.R.S. Employer Jurisdiction of Number) Identification No.) Incorporation) 18 W. Airy Street Norristown, Pennsylvania 19401 ---------------------------------------- ---------- (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: (610) 313-9388 -------------- ------------------------------------------------------------------ (Former Name or Former Address, if Changed Since Last Report)
8-K2nd Page of 3TOC1stPreviousNextBottomJust 2nd
Item 5. Other Events. On June 23, 1998, the Registrant entered into an Agreement and Plan of Reorganization with Cell Pathways, Inc., a Delaware corporation (the "Agreement"). For more details regarding this transaction, please refer to the Agreement, which has been filed as Exhibit 2.1 hereto and is incorporated by reference herein, and the press release dated June 23, 1998, which has been filed as Exhibit 99.1 hereto and is incorporated by reference herein. Item 7. Financial Statements, Pro Forma Financial Information and Exhibits (c) Exhibits Exhibit Number Description -------------- ----------- 2.1 Agreement and Plan of Reorganization, by and between Cell Pathways, Inc. and Tseng Labs, Inc., dated June 23, 1998. 99.1 Press Release issued by the Registrant on June 23, 1998 announcing the proposed transaction with Cell Pathways, Inc.
8-KLast Page of 3TOC1stPreviousNextBottomJust 3rd
SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TSENG LABS, INC. (Registrant) By /s/ Mark H. Karsch -------------------------------- Mark H. Karsch Senior Vice President and Chief Financial Officer Dated: June 23, 1998

Dates Referenced Herein   and   Documents Incorporated by Reference

Referenced-On Page
This ‘8-K’ Filing    Date First  Last      Other Filings
Filed on:6/25/98None on these Dates
For Period End:6/23/9813
 List all Filings 
Top
Filing Submission 0000950116-98-001363   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 26, 11:23:59.1pm ET